$URG
UR-ENERGY INC Stock $urg

$urg Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000165495423002437 Filed on March 06, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$6.447M	$0.00	$19.00K
YoY Change			18.75%
Cost Of Revenue	$6.504M	$1.822M	$6.861M
YoY Change	277.7%	1.84%	-1.99%
Gross Profit	-$57.00K	-$1.822M	-$6.842M
YoY Change	-96.69%	1.84%	-2.03%
Gross Profit Margin	-0.88%		-36010.53%
Selling, General & Admin	$1.422M	$1.266M	$6.037M
YoY Change	-29.81%	2.26%	13.31%
% of Gross Profit
Research & Development	$1.520M	$1.897M	$6.455M
YoY Change	31.03%	15.95%	63.05%
% of Gross Profit
Depreciation & Amortization	$473.0K	$717.0K	$1.768M
YoY Change	3.73%	-26.31%	-1.17%
% of Gross Profit
Operating Expenses	$3.065M	$3.284M	$12.95M
YoY Change	-7.06%	9.65%	32.53%
Operating Profit	-$3.122M	-$5.106M	-$19.79M
YoY Change	-37.81%	6.73%	18.12%
Interest Expense	$2.416M	$201.0K	$463.0K
YoY Change	1288.51%	-96.14%	-106.53%
% of Operating Profit
Other Income/Expense, Net	-$7.000K	$8.000K	$1.255M
YoY Change	-100.56%	-366.67%	62650.0%
Pretax Income	-$713.0K	-$4.897M	-$17.12M
YoY Change	-89.71%	-1263.18%	-25.27%
Income Tax
% Of Pretax Income
Net Earnings	-$713.0K	-$4.897M	-$17.14M
YoY Change	-89.71%	-1263.18%	-25.28%
Net Earnings / Revenue	-11.06%		-90210.53%
Basic Earnings Per Share	$0.00		-$0.08
Diluted Earnings Per Share	$0.00	-$0.02	-$0.08
COMMON SHARES
Basic Shares Outstanding	264.7M shares	223.1M shares	220.5M shares
Diluted Shares Outstanding	241.9B shares		220.5B shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$77.28M	$33.00M	$33.00M
YoY Change	66.85%	-28.55%	-28.55%
Cash & Equivalents	$77.28M	$33.00M	$30.44M
Short-Term Investments
Other Short-Term Assets	$1.198M	$1.030M	$1.030M
YoY Change	-53.71%	-57.61%	-57.61%
Inventory	$6.275M	$9.903M	$9.903M
Prepaid Expenses	$1.198M	$1.030M
Receivables	$10.00K	$8.000K	$8.000K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$84.76M	$43.94M	$43.94M
YoY Change	73.3%	-9.62%	-9.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.67M	$20.13M	$55.81M
YoY Change	-0.91%	-5.31%	-0.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.223M	$8.137M	$8.137M
YoY Change	-48.42%	-48.79%	-48.79%
Total Long-Term Assets	$64.30M	$63.95M	$63.95M
YoY Change	-10.14%	-11.44%	-11.44%
TOTAL ASSETS
Total Short-Term Assets	$84.76M	$43.94M	$43.94M
Total Long-Term Assets	$64.30M	$63.95M	$63.95M
Total Assets	$149.1M	$107.9M	$107.9M
YoY Change	23.73%	-10.71%	-10.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.129M	$660.0K	$660.0K
YoY Change	-17.41%	-22.72%	-22.72%
Accrued Expenses	$798.0K	$577.0K	$577.0K
YoY Change	-65.27%	-72.27%	-72.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.502M	$5.366M	$5.366M
YoY Change	109.36%	311.19%	325.2%
Total Short-Term Liabilities	$8.802M	$6.603M	$6.603M
YoY Change	-5.63%	6.09%	6.09%
LONG-TERM LIABILITIES
Long-Term Debt	$4.607M	$5.710M	$5.710M
YoY Change	-53.05%	-48.72%	-48.37%
Other Long-Term Liabilities	$39.09M	$33.08M	$33.08M
YoY Change	7.91%	-3.18%	-3.18%
Total Long-Term Liabilities	$43.70M	$38.79M	$38.79M
YoY Change	-4.95%	-14.23%	-14.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.802M	$6.603M	$6.603M
Total Long-Term Liabilities	$43.70M	$38.79M	$38.79M
Total Liabilities	$52.50M	$45.40M	$45.40M
YoY Change	-5.06%	-11.77%	-11.77%
SHAREHOLDERS EQUITY
Retained Earnings	-$221.0M	-$220.3M
YoY Change	5.2%	8.44%
Common Stock	$293.6M	$258.6M
YoY Change		4.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$96.56M	$62.50M	$62.50M
YoY Change
Total Liabilities & Shareholders Equity	$149.1M	$107.9M	$107.9M
YoY Change	23.73%	-10.71%	-10.71%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$713.0K	-$4.897M	-$17.14M
YoY Change	-89.71%	-1263.18%	-25.28%
Depreciation, Depletion And Amortization	$473.0K	$717.0K	$1.768M
YoY Change	3.73%	-26.31%	-1.17%
Cash From Operating Activities	$2.327M	-$5.755M	-$18.09M
YoY Change	-204.73%	124.37%	54.65%
INVESTING ACTIVITIES
Capital Expenditures	$665.0K	$496.0K	$709.0K
YoY Change	-1208.33%	-144.01%	-40.42%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$665.0K	-$496.0K	-$709.0K
YoY Change	1008.33%	-55.99%	-40.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$42.70M	-616.0K	$5.893M
YoY Change	1649.88%	-103.72%	-89.26%
NET CHANGE
Cash From Operating Activities	$2.327M	-5.755M	-$18.09M
Cash From Investing Activities	-$665.0K	-496.0K	-$709.0K
Cash From Financing Activities	$42.70M	-616.0K	$5.893M
Net Change In Cash	$44.36M	-6.867M	-$13.02M
YoY Change	24543.89%	-153.42%	-130.97%
FREE CASH FLOW
Cash From Operating Activities	$2.327M	-$5.755M	-$18.09M
Capital Expenditures	$665.0K	$496.0K	$709.0K
Free Cash Flow	$1.662M	-$6.251M	-$18.80M
YoY Change	-176.87%	334.7%	45.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Cash Cash	9068000	usd
CY2021Q4	urg	Current Portion Of Inventory CurrentPortionOfInventory	7923000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9903000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	7923000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40936000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	20804000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40367000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	19107000	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	83000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1168000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2864000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2950180	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.48
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	159982	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.63
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	534425	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.64
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1421932	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.66
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceBeginning	0.61
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1322164	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.14
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	2929101	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.62
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	219055	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.56
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	20408	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.57
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning	10064024	shares
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceBeginning	0.68
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	175000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.74
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	1308625	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	355495	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.66
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	0.66
CY2021	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.061	pure
CY2022	urg	Expected Life Years ExpectedLifeYears	P3Y10M24D
CY2021	urg	Expected Life Years ExpectedLifeYears	P3Y10M24D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.727	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.695	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022	urg	Black Scholes Value Cad BlackScholesValueCad	1.22
CY2021	urg	Black Scholes Value Cad BlackScholesValueCad	0.74
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBeginning	1155928	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning	0.65
CY2020	urg	Number Of Rsus Unvested Granted NumberOfRsusUnvestedGranted	737553	shares
CY2020	urg	Granted Weighted Average Grant Date Fair Value GrantedWeightedAverageGrantDateFairValue	0.48
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod	-475086	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue	0.70
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.61
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBeginning	1011660	shares
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning	0.69
CY2021	urg	Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad	1.44
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning	0.54
CY2021	urg	Number Of Rsus Unvested Granted NumberOfRsusUnvestedGranted	305530	shares
CY2021	urg	Granted Weighted Average Grant Date Fair Value GrantedWeightedAverageGrantDateFairValue	1.14
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod	-638989	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.56
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y8M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	351360000	usd
CY2021	urg	Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate	0.044	pure
CY2021	urg	Per Share Exercise Price Expired PerShareExercisePriceExpired	1.00
CY2020	urg	Outstanding Warrants Issued OutstandingWarrantsIssued	9000000	shares
CY2020	urg	Number Of Shares To Be Issued Upon Exercise Issued NumberOfSharesToBeIssuedUponExerciseIssued	4500000	shares
CY2021	urg	Per Share Exercise Price Issued PerShareExercisePriceIssued	1.35
CY2021	urg	Number Of Warrants Exercised NumberOfWarrantsExercised	-14050920	shares
CY2021	urg	Number Of Shares To Be Issued Upon Exercise Exercised NumberOfSharesToBeIssuedUponExerciseExercised	-7025460	shares
CY2021	urg	Per Share Exercise Price Exercised PerShareExercisePriceExercised	0.98
CY2021	urg	Number Of Warrants Expired NumberOfWarrantsExpired	-573958	shares
CY2021	urg	Number Of Shares To Be Issued Upon Exercise Expired NumberOfSharesToBeIssuedUponExerciseExpired	-286979	shares
CY2020	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning	1.00
CY2020	urg	Per Share Exercise Price Issued PerShareExercisePriceIssued	0.75
CY2022	urg	Class Of Warrant Or Right Outstanding Ending ClassOfWarrantOrRightOutstandingEnding	16730530	shares
CY2021	urg	Class Of Warrants Or Right Shares Issued On Exercise Ending ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding	12184265	shares
CY2021	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending	1.16
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-22908000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-14725000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	46550000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5090000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6017000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.021	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.182	pure
CY2022	urg	Permanent Differences PermanentDifferences	0.011	pure
CY2021	urg	Permanent Differences PermanentDifferences	-0.051	pure
CY2022	urg	True Ups And Other TrueUpsAndOther	0.002	pure
CY2021	urg	True Ups And Other TrueUpsAndOther	0	pure
CY2020	urg	True Ups And Other TrueUpsAndOther	0.008	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.050	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.032	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.042	pure
CY2022	urg	Change In Valuation Allowance ChangeInValuationAllowance	-0.256	pure
CY2021	urg	Change In Valuation Allowance ChangeInValuationAllowance	-0.224	pure
CY2020	urg	Change In Valuation Allowance ChangeInValuationAllowance	-0.393	pure
CY2022	urg	Total Total	0.000	pure
CY2021	urg	Total Total	0.000	pure
CY2020	urg	Total Total	0.000	pure
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001375205
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021	urg	Ending Balance Warrant Liabilities EndingBalanceWarrantLiabilities	6263000	usd
CY2020	urg	Ending Balance Warrant Liabilities EndingBalanceWarrantLiabilities	2144000	usd
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	10064024	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	11910424	shares
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	0.68
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	0.61
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding	1011660	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding	1404962	shares
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	0.69
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	0.54
CY2022	urg	Class Of Warrant Or Right Outstanding Beginning ClassOfWarrantOrRightOutstandingBeginning	24368530	shares
CY2020	urg	Class Of Warrant Or Right Outstanding Ending ClassOfWarrantOrRightOutstandingEnding	22062878	shares
CY2022	urg	Class Of Warrants Or Right Shares Issued On Exercise Beginning ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning	12184265	shares
CY2020	urg	Class Of Warrants Or Right Shares Issued On Exercise Ending ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding	11031439	shares
CY2022	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning	1.16
CY2020	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending	0.90
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2021	urg	Reclassify Assets Held For Sale ReclassifyAssetsHeldForSale	-1536000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2045000	usd
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-33905
CY2022	dei	Entity Registrant Name EntityRegistrantName	UR-ENERGY INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Z4
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	10758 West Centennial Road
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Littleton
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80127
CY2022	dei	City Area Code CityAreaCode	720
CY2022	dei	Local Phone Number LocalPhoneNumber	981-4588
CY2022	dei	Security12b Title Security12bTitle	Common Shares, no par value
CY2022	dei	Trading Symbol TradingSymbol	URG
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	264726804	shares
CY2022Q2	dei	Entity Public Float EntityPublicFloat	228.9	usd
CY2022	dei	Auditor Firm AuditorFirmId	271
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	33003000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	46189000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8000	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	4000	usd
CY2022Q4	urg	Inventory Current InventoryCurrent	9903000	usd
CY2021Q4	urg	Inventory Current InventoryCurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1030000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	894000	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	0	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	1536000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	43944000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	48623000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7923000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8137000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7966000	usd
CY2022Q4	urg	Mineral Properties Noncurrent MineralPropertiesNoncurrent	35682000	usd
CY2021Q4	urg	Mineral Properties Noncurrent MineralPropertiesNoncurrent	35067000	usd
CY2022Q4	urg	Capital Assets CapitalAssets	20132000	usd
CY2021Q4	urg	Capital Assets CapitalAssets	21260000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	63951000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	72216000	usd
CY2022Q4	us-gaap	Assets Assets	107895000	usd
CY2021Q4	us-gaap	Assets Assets	120839000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1168000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2864000	usd
CY2022Q4	urg	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	5366000	usd
CY2021Q4	urg	Current Portion Of Notes Payable CurrentPortionOfNotesPayable	1262000	usd
CY2022Q4	urg	Current Portion Of Warrants Liability CurrentPortionOfWarrantsLiability	0	usd
CY2021Q4	urg	Current Portion Of Warrants Liability CurrentPortionOfWarrantsLiability	2027000	usd
CY2022Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	69000	usd
CY2021Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	71000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6603000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6224000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5694000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	11060000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18000	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	30701000	usd
CY2021Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	29915000	usd
CY2022Q4	urg	Warrant Liability WarrantLiability	2382000	usd
CY2021Q4	urg	Warrant Liability WarrantLiability	4236000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	38793000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	45229000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	258646000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	248319000	usd
CY2022Q4	us-gaap	Surplus Notes SurplusNotes	19843000	usd
CY2021Q4	us-gaap	Surplus Notes SurplusNotes	20040000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4265000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4142000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-220255000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203115000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	62499000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	69386000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107895000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120839000	usd
CY2022	us-gaap	Revenues Revenues	19000	usd
CY2021	us-gaap	Revenues Revenues	16000	usd
CY2020	us-gaap	Revenues Revenues	8316000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	6861000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	7000000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	12968000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-6842000	usd
CY2021	us-gaap	Gross Profit GrossProfit	-6984000	usd
CY2020	us-gaap	Gross Profit GrossProfit	-4652000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	12952000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9773000	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	8689000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-19794000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-16757000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-13341000	usd
CY2022	us-gaap	Interest Expense InterestExpense	463000	usd
CY2021	us-gaap	Interest Expense InterestExpense	733000	usd
CY2020	us-gaap	Interest Expense InterestExpense	710000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1835000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5998000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-680000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	27000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-355000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-72000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1255000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	905000	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	18000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-17140000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-22938000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-14785000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	123000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	435000	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	53000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-17017000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-22503000	usd
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-14732000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022	urg	Diluted Diluted	-0.08
CY2021	urg	Diluted Diluted	-0.12
CY2020	urg	Diluted Diluted	-0.09
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	220496862000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	195691842000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	164257092000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	220496862000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	195691842000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164257092000	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	44333000	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4805000	usd
CY2020	urg	Less Share Issue Costs LessShareIssueCosts	-431000	usd
CY2020	urg	Less Amount Assigned To Warrant Liability Amount LessAmountAssignedToWarrantLiabilityAmount	-860000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	99000	usd
CY2020	urg	Redemption Of Rsus Amount RedemptionOfRsusAmount	-69000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	951000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14732000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34096000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	48672000	usd
CY2021	urg	Less Share Issue Costs LessShareIssueCosts	-2188000	usd
CY2021	urg	Less Amount Assigned To Warrant Liability Amount LessAmountAssignedToWarrantLiabilityAmount	-2604000	usd
CY2021	urg	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	11337000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1785000	usd
CY2021	urg	Redemption Of Rsus Amount RedemptionOfRsusAmount	-288000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1079000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22503000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	69386000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3775000	usd
CY2022	urg	Less Share Issue Costs LessShareIssueCosts	-94000	usd
CY2022	urg	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	4654000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	858000	usd
CY2022	urg	Redemption Of Rsus Amount RedemptionOfRsusAmount	-205000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1142000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17017000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	62499000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17140000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-22938000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14785000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1142000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1080000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	951000	usd
CY2022	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	6861000	usd
CY2021	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	7000000	usd
CY2020	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	7802000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1247000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2045000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2445000	usd
CY2022	us-gaap	Depreciation Depreciation	1768000	usd
CY2021	us-gaap	Depreciation Depreciation	1789000	usd
CY2020	us-gaap	Depreciation Depreciation	1818000	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	460000	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	486000	usd
CY2020	us-gaap	Accretion Expense AccretionExpense	576000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	71000	usd
CY2022	urg	Gain On Loan Forgiveness GainOnLoanForgiveness	0	usd
CY2021	urg	Gain On Loan Forgiveness GainOnLoanForgiveness	-903000	usd
CY2020	urg	Gain On Loan Forgiveness GainOnLoanForgiveness	0	usd
CY2022	urg	Provision For Reclamation ProvisionForReclamation	-2000	usd
CY2021	urg	Provision For Reclamation ProvisionForReclamation	-5000	usd
CY2020	urg	Provision For Reclamation ProvisionForReclamation	4000	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1835000	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	5998000	usd
CY2020	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	680000	usd
CY2022	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	67000	usd
CY2021	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	usd
CY2020	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-16000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-25000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	353000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8841000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7109000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8190000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-136000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-80000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	71000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1696000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	544000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	108000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18091000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11698000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8443000	usd
CY2022	urg	Proceeds From Sale Of Capital Assets ProceedsFromSaleOfCapitalAssets	0	usd
CY2021	urg	Proceeds From Sale Of Capital Assets ProceedsFromSaleOfCapitalAssets	0	usd
CY2020	urg	Proceeds From Sale Of Capital Assets ProceedsFromSaleOfCapitalAssets	18000	usd
CY2022	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	709000	usd
CY2021	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	1190000	usd
CY2020	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	43000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-709000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1190000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3775000	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	48841000	usd
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4805000	usd
CY2022	urg	Share Issue Costs ShareIssueCosts	-94000	usd
CY2021	urg	Share Issue Costs ShareIssueCosts	-2188000	usd
CY2020	urg	Share Issue Costs ShareIssueCosts	-431000	usd
CY2022	urg	Proceeds From Exercise Of Warrants And Stock Options ProceedsFromExerciseOfWarrantsAndStockOptions	3722000	usd
CY2021	urg	Proceeds From Exercise Of Warrants And Stock Options ProceedsFromExerciseOfWarrantsAndStockOptions	8507000	usd
CY2020	urg	Proceeds From Exercise Of Warrants And Stock Options ProceedsFromExerciseOfWarrantsAndStockOptions	99000	usd
CY2022	urg	Rsu Redeemed For Cash RsuRedeemedForCash	-205000	usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	893000	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1305000	usd
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	0	usd
CY2021	urg	Rsu Redeemed For Cash RsuRedeemedForCash	-289000	usd
CY2020	urg	Rsu Redeemed For Cash RsuRedeemedForCash	-39000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2020	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5893000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	54871000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5327000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-108000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13015000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	42028000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3088000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54155000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12127000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15215000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41140000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54155000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12127000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1. </strong><strong>Nature of Operations</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">Ur-Energy Inc. (the “Company”) was incorporated on March 22, 2004 under the laws of the Province of Ontario. The Company continued under the Canada Business Corporations Act on August 8, 2006. The Company is an exploration stage issuer, as defined by U.S. Securities and Exchange Commission (“SEC”). The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located primarily in Wyoming. The Company commenced uranium production at its Lost Creek Project in Wyoming in 2013.</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">Due to the nature of the uranium recovery methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under Subpart 1300 to Regulation S-K (“S-K 1300”), the Company has not determined whether the properties contain mineral reserves. This was true while the Company reported its mineral resources pursuant to National Instrument 43-101 (“NI 43-101”), which uses the Canadian Institute of Mining, Metallurgy and Petroleum (“CIM”) Definition Standards. The Company’s report <em>The Lost Creek ISR Uranium Property, Sweetwater County, Wyoming,</em> March 7, 2022 and as amended on September 19, 2022 (the “Lost Creek Report”) outlines the potential viability of the Lost Creek Property as of December 31, 2021. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from disposition of the properties.</p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The most significant estimates management makes in the preparation of these consolidated financial statements relate to the fair value of stock-based compensation and warrant liabilities using the factors associated with the Black-Scholes calculations, estimation of the amount of recoverable uranium included in the in-process inventory, estimation of factors surrounding asset retirement obligations such as interest rates, discount rates and inflation rates, total cost and the time until the asset retirement commences and the offset of future income taxes through deferred tax assets. Actual results could differ from those estimates.</p>
CY2022	urg	Right Of Use Assets And Liabilities Policytextblock RightOfUseAssetsAndLiabilitiesPolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Right of use assets include storage facility and office equipment leases. We recognize an asset and corresponding liability, which are included in non-current assets and other liabilities in the consolidated balance sheet, based on the present value of the remaining minimum rental payments of the leases. The discount rates used are based on either the Company’s borrowing rate or the imputed interest rate based on the price of the equipment and the lease terms.</p>
CY2022Q4	us-gaap	Cash Cash	2560000	usd
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	30443000	usd
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	37121000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	33003000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	46189000	usd
CY2022Q4	urg	Current Portion Of Inventory CurrentPortionOfInventory	9903000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	6861000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	7000000	usd
CY2022Q4	urg	Cash Pledged For Reclamation CashPledgedForReclamation	8137000	usd
CY2021Q4	urg	Cash Pledged For Reclamation CashPledgedForReclamation	7966000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	8137000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7966000	usd
CY2019Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	43212000	usd
CY2020	urg	Change In Estimated Reclamation Costs ChangeInEstimatedReclamationCosts	-1583000	usd
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2445000	usd
CY2020Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	39184000	usd
CY2021	urg	Change In Estimated Reclamation Costs ChangeInEstimatedReclamationCosts	-536000	usd
CY2021Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	35067000	usd
CY2022	urg	Reclassify Assets No Longer Held For Sale ReclassifyAssetsNoLongerHeldForSale	1536000	usd
CY2022	urg	Change In Estimated Reclamation Costs ChangeInEstimatedReclamationCosts	326000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1247000	usd
CY2022Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	35682000	usd
CY2022Q4	urg	Mineral Property Cost Of The Asset Held For Sale MineralPropertyCostOfTheAssetHeldForSale	0	usd
CY2021Q4	urg	Mineral Property Cost Of The Asset Held For Sale MineralPropertyCostOfTheAssetHeldForSale	1536000	usd
CY2022Q4	urg	Liabilities Associated With The Asset Held For Sale LiabilitiesAssociatedWithTheAssetHeldForSale	0	usd
CY2021Q4	urg	Liabilities Associated With The Asset Held For Sale LiabilitiesAssociatedWithTheAssetHeldForSale	0	usd
CY2022Q4	urg	Asset Held For Sale AssetHeldForSale	0	usd
CY2021Q4	urg	Asset Held For Sale AssetHeldForSale	1536000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20132000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21260000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	660000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	854000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	449000	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1927000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	59000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	5409000	usd
CY2021Q4	us-gaap	Debt Current DebtCurrent	1305000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	43000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	43000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	5366000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1262000	usd
CY2022Q4	urg	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	5727000	usd
CY2021Q4	urg	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	11136000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	33000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	76000	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	5694000	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	11060000	usd
CY2019Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	30972000	usd
CY2020	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	-1583000	usd
CY2020	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	576000	usd
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	29965000	usd
CY2021	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	-536000	usd
CY2021	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	486000	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	29915000	usd
CY2022	urg	Issue Costs IssueCosts	100000	usd
CY2022	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	326000	usd
CY2022	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	460000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	30701000	usd
CY2020	urg	Beginning Balance Warrant Liabilities BeginningBalanceWarrantLiabilities	575000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	860000	usd
CY2020	urg	Mark To Market Revaluation Loss Gain MarkToMarketRevaluationLossGain	680000	usd
CY2020	urg	Effects For Foreign Exchange Rate Changes EffectsForForeignExchangeRateChanges	29000	usd
CY2021	urg	Beginning Balance Warrant Liabilities BeginningBalanceWarrantLiabilities	2144000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2604000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4446000	usd
CY2021	urg	Mark To Market Revaluation Loss Gain MarkToMarketRevaluationLossGain	5998000	usd
CY2021	urg	Effects For Foreign Exchange Rate Changes EffectsForForeignExchangeRateChanges	-37000	usd
CY2022	urg	Beginning Balance Warrant Liabilities BeginningBalanceWarrantLiabilities	6263000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1790000	usd
CY2022	urg	Mark To Market Revaluation Loss Gain MarkToMarketRevaluationLossGain	-1835000	usd
CY2022	urg	Effects For Foreign Exchange Rate Changes EffectsForForeignExchangeRateChanges	-256000	usd
CY2022	urg	Ending Balance Warrant Liabilities EndingBalanceWarrantLiabilities	2382000	usd
CY2020Q3	urg	Direct Offering Closed DirectOfferingClosed	4680000	usd
CY2020Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.52
CY2020Q3	urg	Proceeds From Warrant Exercises One ProceedsFromWarrantExercisesOne	4680000	usd
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	400000	usd
CY2020Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4300000	usd
CY2020Q3	urg	Class Of Warrant Or Right Exercise Price Of Warrants ClassOfWarrantOrRightExercisePriceOfWarrants	0.75
CY2020	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	259640	shares
CY2020Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	100000	usd
CY2020	urg	Proceeds From Options Exercised ProceedsFromOptionsExercised	100000	usd
CY2021Q1	urg	Shares Issued Upon Public Offering SharesIssuedUponPublicOffering	14722200	shares
CY2021Q1	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.90
CY2021Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2208330	shares
CY2021Q1	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	1104165	shares
CY2021Q1	urg	Proceeds From Warrant Exercises One ProceedsFromWarrantExercisesOne	15200000	usd
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	1300000	usd
CY2021Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	13900000	usd
CY2021Q1	urg	Class Of Warrant Or Right Exercise Price Of Warrants ClassOfWarrantOrRightExercisePriceOfWarrants	1.35
CY2021	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	19151457	shares
CY2021Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	33400000	usd
CY2021	urg	Issue Costs IssueCosts	800000	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	32600000	usd
CY2021	urg	Proceeds From Warrants Exercised ProceedsFromWarrantsExercised	6900000	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	14050920	shares
CY2021Q4	urg	Underlying Common Shares UnderlyingCommonShares	7025460	shares
CY2021Q4	urg	Number Of Options Exercisable NumberOfOptionsExercisable	1800000	usd
CY2022	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	2231930	shares
CY2022Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	3800000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	3700000	usd
CY2022	urg	Proceeds From Warrants Exercised ProceedsFromWarrantsExercised	2900000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	7638000	shares
CY2022Q4	urg	Underlying Common Shares UnderlyingCommonShares	3819000	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning	11076583	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceBeginning	0.64
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning	11910424	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.66
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	8574904	shares
CY2022Q4	urg	Number Of Options Exercisable NumberOfOptionsExercisable	900000	usd
CY2020Q4	urg	Number Of Options Exercisable NumberOfOptionsExercisable	100000	usd
CY2022	urg	Share Based Compensation Expenses ShareBasedCompensationExpenses	800000	usd
CY2021	urg	Share Based Compensation Expenses ShareBasedCompensationExpenses	700000	usd
CY2020	urg	Share Based Compensation Expenses ShareBasedCompensationExpenses	600000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	600000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8399904	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6856772	shares
CY2022	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.056	pure
CY2022	urg	Weighted Average Exercise Price WeightedAverageExercisePrice	2.23
CY2021	urg	Weighted Average Exercise Price WeightedAverageExercisePrice	1.44
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	13433	shares
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBeginning	1404962	shares
CY2021	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue	0.63
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	59843	shares
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod	-706130	shares
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue	0.47
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding	305530	shares
CY2022	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	1.14
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	305530	shares
CY2020	urg	Class Of Warrant Or Right Outstanding Beginning ClassOfWarrantOrRightOutstandingBeginning	13062878	shares
CY2020	urg	Class Of Warrants Or Right Shares Issued On Exercise Beginning ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning	6531439	shares
CY2022	urg	Per Share Exercise Price Exercised PerShareExercisePriceExercised	0.75
CY2021	urg	Class Of Warrant Or Right Outstanding Beginning ClassOfWarrantOrRightOutstandingBeginning	22062878	shares
CY2021	urg	Class Of Warrants Or Right Shares Issued On Exercise Beginning ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning	11031439	shares
CY2021	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning	0.90
CY2021	urg	Outstanding Warrants Issued OutstandingWarrantsIssued	16930530	shares
CY2021	urg	Number Of Shares To Be Issued Upon Exercise Issued NumberOfSharesToBeIssuedUponExerciseIssued	8465265	shares
CY2021	urg	Class Of Warrant Or Right Outstanding Ending ClassOfWarrantOrRightOutstandingEnding	24368530	shares
CY2022	urg	Number Of Warrants Exercised NumberOfWarrantsExercised	-7638000	shares
CY2022	urg	Number Of Shares To Be Issued Upon Exercise Exercised NumberOfSharesToBeIssuedUponExerciseExercised	-3819000	shares
CY2022	urg	Class Of Warrants Or Right Shares Issued On Exercise Ending ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding	8365265	shares
CY2022	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending	1.35
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19000	usd
CY2022	urg	Concentration Risk Percentages1 ConcentrationRiskPercentages1	1.000	pure
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16000	usd
CY2021	urg	Concentration Risk Percentages1 ConcentrationRiskPercentages1	1.000	pure
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8316000	usd
CY2020	urg	Concentration Risk Percentages1 ConcentrationRiskPercentages1	1.000	pure
CY2022Q1	us-gaap	Royalty Expense RoyaltyExpense	1300000	usd
	urg	Sba Ppp Loan SbaPppLoan	893000	usd
	urg	Accrued Interest AccruedInterest	10000	usd
CY2021	us-gaap	Other Income OtherIncome	903000	usd
CY2022	urg	Cost Of Product Sales CostOfProductSales	0	usd
CY2021	urg	Cost Of Product Sales CostOfProductSales	0	usd
CY2020	urg	Cost Of Product Sales CostOfProductSales	5166000	usd
CY2022	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	6861000	usd
CY2021	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	7000000	usd
CY2020	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	7802000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6861000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7000000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12968000	usd
CY2022	us-gaap	Exploration Expense ExplorationExpense	1769000	usd
CY2021	us-gaap	Exploration Expense ExplorationExpense	2037000	usd
CY2020	us-gaap	Exploration Expense ExplorationExpense	1816000	usd
CY2022	us-gaap	Development Costs DevelopmentCosts	4686000	usd
CY2021	us-gaap	Development Costs DevelopmentCosts	1922000	usd
CY2020	us-gaap	Development Costs DevelopmentCosts	1097000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6037000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5328000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5200000	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	460000	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	12952000	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9773000	usd
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8689000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33003000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46189000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4268000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8137000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7966000	usd
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7859000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41140000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54155000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12127000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	700000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	800000	usd
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	800000	usd
CY2022	urg	Summary Of Income Before Income Tax Provisiontabletextblock SummaryOfIncomeBeforeIncomeTaxProvisiontabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> <strong> Year Ended December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Income (Loss) before Income Tax Provision</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">United States</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(15,638</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(13,438</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11,164</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Canada</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,481</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(9,470</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,561</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(17,119</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(22,908</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(14,725</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr></tbody></table>
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-17119000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	13243000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	12841000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	11184000	usd
CY2022Q4	urg	Deferred Tax Assets Operating Loss Carryforwards Noncurrent DeferredTaxAssetsOperatingLossCarryforwardsNoncurrent	42074000	usd
CY2021Q4	urg	Deferred Tax Assets Operating Loss Carryforwards Noncurrent DeferredTaxAssetsOperatingLossCarryforwardsNoncurrent	38800000	usd
CY2020Q4	urg	Deferred Tax Assets Operating Loss Carryforwards Noncurrent DeferredTaxAssetsOperatingLossCarryforwardsNoncurrent	35366000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	55317000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51641000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	46550000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	55317000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	51641000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3676000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265	pure
CY2020	urg	Permanent Differences PermanentDifferences	-0.020	pure
CY2022	urg	Share Issuance Costs ShareIssuanceCosts	0.034	pure
CY2021	urg	Share Issuance Costs ShareIssuanceCosts	0	pure
CY2020	urg	Share Issuance Costs ShareIssuanceCosts	0	pure
CY2022	urg	Itc Credits ItcCredits	0.015	pure
CY2021	urg	Itc Credits ItcCredits	0	pure
CY2020	urg	Itc Credits ItcCredits	0	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	12000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	20000	usd
CY2023	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	5409000	usd
CY2024	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	5727000	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	11136000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	600000	usd
CY2022Q4	urg	Concentration Of Risk Cash And Cash Equivalents ConcentrationOfRiskCashAndCashEquivalents	40600000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	1200000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	5400000	usd
CY2022Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	33000000.0	usd

Files In Submission

Name	View Source	Status
0001654954-23-002437-index-headers.html	Edgar Link	pending
0001654954-23-002437-index.html	Edgar Link	pending
0001654954-23-002437.txt	Edgar Link	pending
0001654954-23-002437-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
urg-20221231.xsd	Edgar Link	pending
urg_10k.htm	Edgar Link	pending
urg_10kimg16.jpg	Edgar Link	pending
urg_10kimg17.jpg	Edgar Link	pending
urg_10kimg18.jpg	Edgar Link	pending
urg_10kimg19.jpg	Edgar Link	pending
urg_10kimg20.jpg	Edgar Link	pending
urg_10kimg21.jpg	Edgar Link	pending
urg_10kimg22.jpg	Edgar Link	pending
urg_10kimg23.jpg	Edgar Link	pending
urg_ex211.htm	Edgar Link	pending
urg_ex211img1.jpg	Edgar Link	pending
urg_ex231.htm	Edgar Link	pending
urg_ex231img1.jpg	Edgar Link	pending
urg_ex232.htm	Edgar Link	pending
urg_ex311.htm	Edgar Link	pending
urg_ex312.htm	Edgar Link	pending
urg_ex321.htm	Edgar Link	pending
urg_ex322.htm	Edgar Link	pending
urg_ex42.htm	Edgar Link	pending
urg-20221231_cal.xml	Edgar Link	unprocessable
urg-20221231_def.xml	Edgar Link	unprocessable
urg-20221231_lab.xml	Edgar Link	unprocessable
urg-20221231_pre.xml	Edgar Link	unprocessable
urg_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$URG
UR-ENERGY INC Stock $urg

2023 Q1 Form 10-K Financial Statement

#000165495423002437 Filed on March 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG UR-ENERGY INC Stock $urg

2023 Q1 Form 10-K Financial Statement

#000165495423002437 Filed on March 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG
UR-ENERGY INC Stock $urg